Published in Obesity and Diabetes Week, October 3rd, 2005
"Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide [GIP]) is an important incretin hormone secreted by endocrine K-cells in response to nutrient ingestion. In this study, we investigated the effects of chemical ablation of GIP receptor (GIP-R) Action on aspects of obesity-related diabetes using a stable and specific GIP-R antagonist, (Pro 3)GIP," scientists in the United Kingdom report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week